Log In
BCIQ
Print this Print this
 

Fasidotril (BP 1.137)

  Manage Alerts
Collapse Summary General Information
Company Bioprojet Pharma S.a.r.l.
DescriptionMixed inhibitor of neprilysin (NEP) and angiotensin-converting enzyme (ACE)
Molecular Target Angiotensin-converting enzyme (ACE) ; Neutral endopeptidase (neprilysin) (MME) (NEP) (CD10)
Mechanism of ActionAngiotensin-converting enzyme (ACE) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationMyocardial infarction (MI)
Indication DetailsTreat myocardial infarction (MI)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today